Search Results - "Ruzyłło, Witold"

Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland by Poloński, Lech, Gasior, Mariusz, Gierlotka, Marek, Kalarus, Zbigniew, Cieśliński, Andrzej, Dubiel, Jacek S, Gil, Robert J, Ruzyłło, Witold, Trusz-Gluza, Maria, Zembala, Marian, Opolski, Grzegorz

“…In Poland, together with the transformation of the political system, significant positive changes have been made to the national health care system. This…”
Get full text

Hemoglobin, Leukocytosis and Clinical Outcomes of ST-Elevation Myocardial Infarction Treated With Primary Angioplasty: Anin Myocardial Infarction Registry by Kruk, Mariusz, Przyluski, Jakub, Kalinczuk, Lukasz, Pregowski, Jerzy, Kadziela, Jacek, Kaczmarska, Edyta, Petryka, Joanna, Kepka, Cezary, Klopotowski, Mariusz, Chmielak, Zbigniew, Ciszewski, Andrzej, Demkow, Marcin, Karcz, Maciej, Witkowski, Adam, Ruzyllo, Witold

“…Background Hemoglobin (Hb) levels may interact with inflammatory activation, but it is unknown whether the interaction has any impact on clinical outcomes in…”
Get full text

Workstation-Based Calculation of CTA-Based FFR for Intermediate Stenosis by Kruk, Mariusz, PhD, Wardziak, Łukasz, MD, Demkow, Marcin, PhD, Pleban, Weronika, MS, Pręgowski, Jerzy, PhD, Dzielińska, Zofia, PhD, Witulski, Marek, PhD, Witkowski, Adam, PhD, Rużyłło, Witold, PhD, Kępka, Cezary, PhD

“…Abstract Objectives This study sought to evaluate the proportion of patients with intermediate coronary stenosis diagnosed on computed tomography angiography…”
Get full text

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial by Tendera, Michał, Wojakowski, Wojciech, Rużyłło, Witold, Chojnowska, Lidia, Kępka, Cezary, Tracz, Wiesława, Musiałek, Piotr, Piwowarska, Wiesława, Nessler, Jadwiga, Buszman, Paweł, Grajek, Stefan, Bręborowicz, Piotr, Majka, Marcin, Ratajczak, Mariusz Z.

“…Aims Comparison of intracoronary infusion of bone marrow (BM)-derived unselected mononuclear cells (UNSEL) and selected CD34+CXCR4+ cells (SEL) in patients…”
Get full text

Impact of Coronary Artery Calcium Characteristics on Accuracy of CT Angiography by Kruk, Mariusz, MD, PhD, Noll, Dariusz, MD, Achenbach, Stefan, MD, PhD, Mintz, Gary S., MD, Pręgowski, Jerzy, MD, PhD, Kaczmarska, Edyta, MD, Kryczka, Karolina, MD, Pracoń, Radosław, MD, PhD, Dzielińska, Zofia, MD, PhD, Śleszycka, Justyna, MD, PhD, Witkowski, Adam, MD, PhD, Demkow, Marcin, MD, PhD, Rużyłło, Witold, MD, PhD, Kępka, Cezary, MD, PhD

“…Objectives This study sought to evaluate which specific calcium characteristics impact diagnostic accuracy of coronary computed tomography angiography (CTA)…”
Get full text

Edoxaban versus Warfarin in Patients with Atrial Fibrillation by Giugliano, Robert P, Ruff, Christian T, Braunwald, Eugene, Murphy, Sabina A, Wiviott, Stephen D, Halperin, Jonathan L, Waldo, Albert L, Ezekowitz, Michael D, Weitz, Jeffrey I, Špinar, Jindřich, Ruzyllo, Witold, Ruda, Mikhail, Koretsune, Yukihiro, Betcher, Joshua, Shi, Minggao, Grip, Laura T, Patel, Shirali P, Patel, Indravadan, Hanyok, James J, Mercuri, Michele, Antman, Elliott M

“…Edoxaban, an oral factor Xa inhibitor, was noninferior to warfarin in the prevention of stroke or systemic embolism in patients with atrial fibrillation. There…”
Get full text

Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome by Alexander, John H, Lopes, Renato D, James, Stefan, Kilaru, Rakhi, He, Yaohua, Mohan, Puneet, Bhatt, Deepak L, Goodman, Shaun, Verheugt, Freek W, Flather, Marcus, Huber, Kurt, Liaw, Danny, Husted, Steen E, Lopez-Sendon, Jose, De Caterina, Raffaele, Jansky, Petr, Darius, Harald, Vinereanu, Dragos, Cornel, Jan H, Cools, Frank, Atar, Dan, Leiva-Pons, Jose Luis, Keltai, Matyas, Ogawa, Hisao, Pais, Prem, Parkhomenko, Alexander, Ruzyllo, Witold, Diaz, Rafael, White, Harvey, Ruda, Mikhail, Geraldes, Margarida, Lawrence, Jack, Harrington, Robert A, Wallentin, Lars

“…In a randomized trial, patients with an acute coronary syndrome were assigned to receive apixaban or placebo in addition to standard therapy. The apixaban…”
Get full text

Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes by Tricoci, Pierluigi, Huang, Zhen, Held, Claes, Moliterno, David J, Armstrong, Paul W, Van de Werf, Frans, White, Harvey D, Aylward, Philip E, Wallentin, Lars, Chen, Edmond, Lokhnygina, Yuliya, Pei, Jinglan, Leonardi, Sergio, Rorick, Tyrus L, Kilian, Ann M, Jennings, Lisa H.K, Ambrosio, Giuseppe, Bode, Christoph, Cequier, Angel, Cornel, Jan H, Diaz, Rafael, Erkan, Aycan, Huber, Kurt, Hudson, Michael P, Jiang, Lixin, Jukema, J. Wouter, Lewis, Basil S, Lincoff, A. Michael, Montalescot, Gilles, Nicolau, José Carlos, Ogawa, Hisao, Pfisterer, Matthias, Prieto, Juan Carlos, Ruzyllo, Witold, Sinnaeve, Peter R, Storey, Robert F, Valgimigli, Marco, Whellan, David J, Widimsky, Petr, Strony, John, Harrington, Robert A, Mahaffey, Kenneth W

“…In this trial, vorapaxar, a protease-activated–receptor 1 antagonist that inhibits thrombin-induced platelet activation, was not effective in reducing the…”
Get full text

Reintervention and Survival After Transcatheter Pulmonary Valve Replacement by McElhinney, Doff B, Zhang, Yulin, Levi, Daniel S, Georgiev, Stanimir, Biernacka, Elżbieta Katarzyna, Goldstein, Bryan H, Shahanavaz, Shabana, Qureshi, Athar M, Cabalka, Allison K, Bauser-Heaton, Holly, Torres, Alejandro J, Morray, Brian H, Armstrong, Aimee K, Millan-Iturbe, Oscar, Peng, Lynn F, Aboulhosn, Jamil A, Rużyłło, Witold, Berger, Felix, Sondergaard, Lars, Schranz, Dietmar, Cheatham, John P, Jones, Thomas K, Ewert, Peter, Schubert, Stephan

“…Transcatheter pulmonary valve (TPV) replacement (TPVR) has become the standard therapy for postoperative pulmonary outflow tract dysfunction in patients with a…”
Get full text

Bedside prediction of 9-year mortality after ST‑segment elevation myocardial infarction treated with primary percutaneous coronary intervention by Polańska-Skrzypczyk, Magdalena, Karcz, Maciej, Rużyłło, Witold, Witkowski, Adam

“…Despite similar underlying pathogenesis, clinical features, and management of ST‑segment elevation myocardial infarction (STEMI), the long‑term prognosis of…”
Get full text

Prevalence and Characteristics of Coronary Anomalies Originating from the Opposite Sinus of Valsalva in 8,522 Patients Referred for Coronary Computed Tomography Angiography by Opolski, Maksymilian P., MD, Pregowski, Jerzy, MD, Kruk, Mariusz, MD, Witkowski, Adam, MD, Kwiecinska, Sonia, MS, Lubienska, Ewa, MS, Demkow, Marcin, MD, Hryniewiecki, Tomasz, MD, Michalek, Piotr, MD, Ruzyllo, Witold, MD, Kepka, Cezary, MD

“…Although coronary computed tomographic angiography has the ability to depict potentially malignant features of anomalous coronary artery originating from the…”
Get full text

Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial by Pol, Tymon, Held, Claes, Westerbergh, Johan, Lindbäck, Johan, Alexander, John H., Alings, Marco, Erol, Cetin, Goto, Shinya, Halvorsen, Sigrun, Huber, Kurt, Hanna, Michael, Lopes, Renato D., Ruzyllo, Witold, Granger, Christopher B., Hijazi, Ziad

“…Background Dyslipidemia is a major risk factor for cardiovascular events. The prognostic importance of lipoproteins in patients with atrial fibrillation is not…”
Get full text

Sudden death in noncoronary heart disease is associated with delayed paced ventricular activation by SAUMAREZ, Richard C, CHOJNOWSKA, Lidia, DERKSEN, Richard, PYTKOWSKI, Mariusz, STERLINSKI, Maciej, HUANG, Christopher L.-H, SADOUL, Nicolas, HAUER, Richard N. W, RUZYLLO, Witold, GRACE, Andrew A

“…Slowed or delayed myocardial activation and dispersed refractoriness predispose to reentrant excitation that may lead to ventricular fibrillation (VF)…”
Get full text

Effect of Torcetrapib on the Progression of Coronary Atherosclerosis by Nissen, Steven E, Tardif, Jean-Claude, Nicholls, Stephen J, Revkin, James H, Shear, Charles L, Duggan, William T, Ruzyllo, Witold, Bachinsky, William B, Lasala, Gabriel P, Tuzcu, E. Murat

“…In this 24-month clinical trial, torcetrapib, a cholesteryl ester transfer protein inhibitor, failed to cause regression of coronary atherosclerosis, as seen…”
Get full text

Femoral rather than carotid artery ultrasound imaging predicts extent and severity of coronary artery disease by Sosnowski, Cezary, Pasierski, Tomasz, Janeczko-Sosnowska, Ewa, Szulczyk, Anna, Dabrowski, Rafał, Woźniak, Jacek, Sumiński, Andrzej, Ruzyłło, Witold

“…Pathological, epidemiological and clinical studies indicate that there is coexistence between peripheral vascular disease and coronary artery disease (CAD)…”
Get full text

A Closer Look at Frederic Chopin's Cause of Death by Witt, Michał, Szklener, Artur, Kawecki, Jerzy, Rużyłło, Witold, Negrusz-Kawecka, Marta, Jeleń, Michał, Langfort, Renata, Marchwica, Wojciech, Dobosz, Tadeusz

Get full text

Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD) by Kukuła, Krzysztof, MD, PhD, Chojnowska, Lidia, MD, PhD, Dąbrowski, Maciej, MD, Witkowski, Adam, MD, PhD, Chmielak, Zbigniew, MD, PhD, Skwarek, Mirosław, MD, PhD, Kądziela, Jacek, MD, PhD, Teresińska, Anna, PhD, Małecki, Maciej, MD, PhD, Janik, Przemysław, MD, PhD, Lewandowski, Zbigniew, PhD, Kłopotowski, Mariusz, MD, Wnuk, Jacek, MD, PhD, Rużyłło, Witold, MD, PhD

“…Background VIF-CAD randomized, placebo-controlled, double-blind trial was an attempt to induce therapeutic angiogenesis by percutaneous intramyocardial…”
Get full text

Long-term follow-up and safety assessment of angiogenic gene therapy trial VIF-CAD: Transcatheter intramyocardial administration of a bicistronic plasmid expressing VEGF-A165/bFGF cDNA for the treatment of refractory coronary artery disease by Kukuła, Krzysztof, Urbanowicz, Arkadiusz, Kłopotowski, Mariusz, Dąbrowski, Maciej, Pręgowski, Jerzy, Kądziela, Jacek, Chmielak, Zbigniew, Witkowski, Adam, Rużyłło, Witold

“…There have been a number of angiogenic gene therapy trials, yielding mixed results as to efficacy, but demonstrating uniform short-term treatment safety. Data…”
Get full text

Long-term follow-up of patients with percutaneous mitral commissurotomy by Chmielak, Zbigniew, Kruk, Mariusz, Demkow, Marcin, Kłopotowski, Mariusz, Konka, Marek, Ruzyłło, Witold

“…Percutaneous mitral commissurotomy (PMC) has become the procedure of choice for patients with isolated mitral stenosis. To assess immediate and long-term…”
Get full text

Pentalogy of Fallot by Milczanowski, Kacper, Tyczyński, Paweł, Kukuła, Krzysztof, Michałowska, Ilona, Kowalik, Ewa, Kowalik, Ilona, Mazurkiewicz, Łukasz, Biernacka, Elżbieta K, Różański, Jacek, Demkow, Marcin, Rużyłło, Witold, Witkowski, Adam, Hoffman, Piotr

Get full text